维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Schellhammer P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A re-assessment of the role of combined androgen blockade for advanced prostate cancer 显示文摘	Klotz L Schellhammer P Carroll K	2004	BJU Int2004，93，：	1
2	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine显示文摘	Vlahou A Schellhammer P F Mendrinos S	2001	Am J Pathol2001，158，4：	1
3	Augologous dendritc cells pulsed with prostatic acid phosphatase (APC8015) for hormone refractory prostate cancer:a phsae Ⅲ randomized, double blind, placebo controlled trial显示文摘	Schellhammer P Small E J Higano C S	2002	Proceedings of ASCO Volume2002，21，18：	1
4	The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis 显示文摘	Kuban D A el-Mahdi A M Schellhammer P F	1985	Cancer1985，56，4：	1
5	Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade显示文摘	SCHELLHAMMER PF VENNER P HAAS GP	1997	J Urol1997，157，5：	1
6	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘	Vlahou A Schellhammer P F Mendrinos S	2001	Am J Pathol2001，158，：	1
7	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
8	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
9	Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade显示文摘	SCHELLHAMMER PF VENNER P HAAS GP	1997	J Urol1997，157，5：	1
10	Sipuleu-cel-T显示文摘	HIGANO CS SMALL EJ SCHELLHAMMER P	2010	A^ai Rev Drug Discov2010，9，7：	1
11	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
12	Integrated data from 2 randomized, double-bhnd, placebo-controlled, phase 3 trials of active cellular immunotherapy with tate cancer显示文摘	Higano C S Schellhammer P F Small E J	2009	Cancer2009，115，16：	1
13	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
14	Pre- malignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum显示文摘	Schellhammer P F Jordan G H Robey E L	1992	Urol Clin North Am1992，19，1：	1
15	A re-assessment of the role of combined androgen blockade for advanced prostate cancer显示文摘	Klotz L Schellhammer P Carroll K	2004	BJU Int2004，93，9：	1
16	Role of estrogen in normal male function:clinical implications for patients with prostate cancer on androgen deprivation therapy显示文摘	Wibowo E Schellhammer P Wassersug RJ	2011	J Urol2011，185，1：	1
17	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy M F Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
18	Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients显示文摘	Qu Y Adam B L Yasui Y Ward M D Cazares L H Schellhammer P F	2002	Clin Chem2002，48，：	1
19	Long-term follow-up of intravesical bacillus Calmette-Guerin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra 显示文摘	TAYLOR JH DAVIS J SCHELLHAMMER P	2007	Clin Genitourin Cancer2007，5，6：	1
20	Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘	VLAHOU A SCHELLHAMMER P F MENDRINOS S	2001	Am J Pathol2001，158，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示